Clinical trial
Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases…
NCT00259844 · Cancer Research UK, Other · Completed
Key facts
| NCT number | NCT00259844 |
|---|---|
| Title | Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed |
| Official title | A Phase 2 Study Immunologically Evaluating 5T4-MVA (TroVax) in Patients Undergoing Surgical Resection of Colorectal Liver Metastases |
| Lead sponsor | Cancer Research UK, Other |
| Collaborators | Oxford BioMedica Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Biological |
| Interventions | TroVax |
| Enrollment | 20 |
| Start date | Jun 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Jul 18, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: